CompletedNot Applicable

The Platinum Study Comparison Group

United States102 participantsStarted 2015-05

Plain-language summary

The patients enrolled on this new study will serve as an appropriate comparison group consisting of patients with the diagnosis of germ cell testicular cancer who were cured with surgical resection and did not receive cisplatin-based chemotherapy with a group of patients from another study who did receive cisplatin-based chemotherapy.

Who can participate

Age range18 Years – 55 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis or confirmation of diagnosis of a histologically or serologically confirmed testicular germ cell tumor (GCT) or GCT at another anatomic location * Age at GCT diagnosis: 55 years of age or younger * Males, 18 years of age or older at time of study consent * Subject is able to provide consent * Subject is able to speak and read English * Treatment consisted of surgery only (i.e., orchiectomy and/or retroperitoneal lymph node dissection \[RPLND\]) for either initial testicular germ cell tumor (GCT) or subsequent testicular cancer * Subject completed surgery \> 1 year ago * Subject is currently undergoing active follow-up at IU * Subject did not require any subsequent chemotherapy, salvage chemotherapy treatment or bone marrow transplant. * Subject had no prior chemotherapy of any kind Exclusion Criteria: * Patients with prior chemotherapy (whether for GCT or any other cancer)

What they're measuring

Proportion of patients with ototoxicity

Timeframe: 1 year after surgery

Proportion of patients with neurotoxicity

Timeframe: 1 year after surgery

Trial details

NCT IDNCT02890030

SponsorLawrence Einhorn

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-06-14

View on ClinicalTrials.gov More Testicular Neoplasms trials